IQV
IQVIA Holdings Inc. · Healthcare · Medical - Diagnostics & Research
Señales de momentum (gestores comparables):
amplitud de titulares +5.0% ·
flujo de acciones +13.6% ·
nuevas posiciones netas +4.8%
· fórmula
Acumulación amplia: acciones en aumento entre más titulares
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q4 2024
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | 0 | 393.01K | $104.01M | n/a | −1 |
| Q2 2026 | 164 | +9 | 122.10M | $23.56B | +12 | −4 |
| Q1 2026 | 159 | -11 | 122.65M | $21.04B | +3 | −15 |
| Q4 2025 | 169 | +1 | 132.77M | $29.93B | +3 | −1 |
| Q3 2025 | 26 | -1 | 77.42M | $14.69B | +1 | −3 |
| Q2 2025 | 25 | +2 | 68.72M | $10.83B | +2 | n/a |
| Q1 2025 | 20 | -1 | 30.89M | $5.44B | n/a | −1 |
| Q4 2024 | 21 | +1 | 31.11M | $6.11B | +1 | n/a |
| Q3 2024 | 19 | -1 | 19.49M | $4.61B | +1 | −2 |
| Q2 2024 | 20 | n/a | 21.58M | $4.56B | n/a | n/a |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Harris Associates (Oakmark) ✦ | 11.34M | +11.4% | $2.23B | 3.7% | ▲ Add | 3 | SEC ↗ ×2 |
| 2 | State Street Global Advisors ✦ (pasivo) | 7.88M | n/a | $1.55B | 0.1% | n/c | 1 | SEC ↗ |
| 3 | Geode Capital Management ✦ (pasivo) | 4.18M | +1.9% | $818.31M | 0.1% | ▲ Add | 3 | SEC ↗ ×2 |
| 4 | Norges Bank ✦ (pasivo) | 1.71M | +1.3% | $336.04M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 5 | Millennium Management ✦ | 1.37M | +301.6% | $269.33M | 0.2% | ▲ Add | 3 | SEC ↗ |
| 6 | D. E. Shaw & Co. ✦ | 965.30K | +211.2% | $189.69M | 0.2% | ▲ Add | 3 | SEC ↗ ×2 |
| 7 | Marshall Wace ✦ | 954.29K | +85.4% | $187.53M | 0.2% | ▲ Add | 3 | SEC ↗ ×3 |
| 8 | Two Sigma Investments ✦ | 767.98K | +98.4% | $150.92M | 0.4% | ▲ Add | 3 | SEC ↗ |
| 9 | Capital World Investors ✦ | 587.87K | -11.8% | $115.52M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 10 | AQR Capital Management ✦ | 427.24K | +125.3% | $83.96M | 0.1% | ▲ Add | 3 | SEC ↗ ×5 |
| 11 | PRIMECAP Management ✦ | 294.99K | -9.5% | $57.97M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 12 | T. Rowe Price ✦ | 288.51K | -30.1% | $56.70M | 0.0% | ▼ Trim | 3 | SEC ↗ ×2 |
| 13 | Citadel Advisors ✦ | 87.94K | -37.0% | $17.28M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 14 | Markel Group ✦ | 58.73K | 0.0% | $11.54M | 0.1% | Held | 3 | SEC ↗ |
| 15 | Renaissance Technologies ✦ | 46.85K | -26.3% | $9.21M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 16 | Adage Capital Partners ✦ | 38.86K | +63.7% | $7.64M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 17 | Arrowstreet Capital ✦ | 37.76K | -21.8% | $7.42M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 18 | Gotham Asset Management ✦ | 31.36K | +11.8% | $6.16M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 19 | Duquesne Family Office ✦ | 21.50K | Nuevo | $4.22M | 0.1% | New | 1 | SEC ↗ |
| 20 | Fisher Asset Management ✦ | 15.70K | +112.2% | $3.08M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 21 | Wellington Management ✦ | 9.79K | +12.7% | $1.92M | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
"Their weight" = la participación de la posición en el valor de renta variable 13F reportado por ese manager: la medida de convicción. ✦ = manager curado.
Nuevos compradores
| Duquesne Family Office | $4.22M | 0.1% |
Posición cerrada
| Sin salidas rastreadas este trimestre. |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 1,061 tenedores, 150.48M acciones, $24.99B declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué más suelen tener los titulares rastreados de este valor: recuentos de titularidad compartida, no relaciones fundamentales.
Compras en mercado abierto (P)
Sin compras en mercado abierto por parte de insiders en nuestra ventana de cobertura.
Ventas en mercado abierto (S)
Officer · 2.67K acc. · $697,228
Las adjudicaciones, ejercicios y retenciones fiscales nunca se contabilizan aquí como compras o ventas. Metodología